Ajinomoto (2802) Investor update summary
Event summary combining transcript, slides, and related documents.
Investor update summary
27 Aug, 2026Key strategic themes
Accelerating purpose-driven management through the Medium-Term ASV Initiatives 2030 Roadmap, focusing on marketing evolution and digital transformation (DX) to achieve ambitious ASV indicators.
Aspiration to extend healthy life expectancy for 1 billion people and reduce environmental impact by 50% through amino science.
Medium-term management targets for 2030 include tripling EPS, raising ROE to 20%, and ROIC to 17%, with organic sales growth of 5% or more annually from FY2025.
Employee engagement and brand value are key intangible assets, with targets to raise engagement scores to 85%+ and brand value to $2.39 billion by FY2030.
Emphasis on employee-driven transformation and leveraging digital technology for corporate value enhancement.
Marketing transformation
Marketing Design Center (MDC) established to foster innovation, develop talent, and integrate digital and mass media strategies, functioning as both a profit and service center.
D2C Dept. launched in April 2024 to integrate direct consumer channels, support existing businesses, and expand marketing investment effects.
D2C business model is shifting from single-item repeat orders to fan-building through brand attachment and content marketing.
Influencer and ambassador programs are expanding, aiming for 100 million followers by 2030 and achieving ¥5.65 billion in media exposure in FY2023, a 1.7x increase year-on-year.
Brand investment and marketing mix modeling have improved efficiency, ROI, and market share in key products.
Product and communication strategy innovation
Product development reformed to integrate MDC throughout the process, enabling mass production of hit products.
Successful launches include Cook Do Premium Mala Mapo Tofu and Pasta Cube, leveraging consumer insights and agile marketing.
Transitioning from mass media to the PESO (Paid, Earned, Shared, Owned) model, integrating online and offline communication.
Latest events from Ajinomoto
- Amino acid innovation powers global growth, health, and sustainability, with strong returns.2802
Corporate presentation - Record Q1 sales and profit led to upward full-year guidance amid strong electronic materials demand.2802
Q1 2027 - Global leader in amino acid science targets growth, health impact, and major sustainability gains.2802
Investor presentation - AI-driven demand and innovation boost ABF growth, margins, and capacity expansion.2802
Investor update - Record sales and profit highs, with raised full-year profit outlook and strong segment momentum.2802
Q3 2026 - Doubling medical food sales by 2030 through 20%+ growth, innovation, and global expansion.2802
Investor update - CDMO revenue is set to triple by FY2030 as Forge Biologics drives gene therapy growth.2802
Investor Day 2024 - Sales up 7.7% with record profit, but net profit fell 12% on tax; guidance unchanged.2802
Q1 2025 - Record sales and profit growth led to upward forecasts and increased shareholder returns.2802
Q2 2025